Proton Pump Inhibitors and Risk of Fracture: A Systematic Review and Meta-Analysis of Observational Studies
暂无分享,去创建一个
[1] A. Bredenoord,et al. Gastro-oesophageal reflux disease , 2000, The Lancet.
[2] J. Higgins. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration , 2011 .
[3] Michele Tarsilla. Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.
[4] D. Corley,et al. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. , 2010, Gastroenterology.
[5] B. Mcgowan,et al. Prescribing of anti‐osteoporotic therapies following the use of proton pump inhibitors in general practice , 2010, Pharmacoepidemiology and drug safety.
[6] C. Cooper,et al. Use of proton pump inhibitors and risk of hip/femur fracture: a population-based case-control study , 2010, Osteoporosis International.
[7] J. Manson,et al. Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative. , 2010, Archives of internal medicine.
[8] L. Lix,et al. Proton-pump inhibitor use is not associated with osteoporosis or accelerated bone mineral density loss. , 2010, Gastroenterology.
[9] C. Cooper,et al. Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphosphonates , 2009, Osteoporosis International.
[10] F. Chan,et al. Guidelines for Prevention of NSAID-Related Ulcer Complications , 2009, The American Journal of Gastroenterology.
[11] D. Bauer,et al. Acid-Suppressive Medications and Risk of Bone Loss and Fracture in Older Adults , 2008, Calcified Tissue International.
[12] L. Lix,et al. Use of proton pump inhibitors and risk of osteoporosis-related fractures , 2008, Canadian Medical Association Journal.
[13] H. Jick,et al. Proton Pump Inhibitor Use and Risk of Hip Fractures in Patients without Major Risk Factors , 2008, Pharmacotherapy.
[14] G. Guyatt,et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.
[15] D. Felsenberg,et al. Increase in Vertebral Fracture Risk in Postmenopausal Women Using Omeprazole , 2008, Calcified Tissue International.
[16] Andrew Herxheimer,et al. Systematic reviews of adverse effects: framework for a structured approach , 2007, BMC medical research methodology.
[17] Suzanne G. Leveille,et al. Relationship of homocysteine levels to quadriceps strength, gait speed, and late-life disability in older adults. , 2007, The journals of gerontology. Series A, Biological sciences and medical sciences.
[18] A. Tosteson,et al. Incidence and Economic Burden of Osteoporosis‐Related Fractures in the United States, 2005–2025 , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[19] Yu-Xiao Yang,et al. Long-term proton pump inhibitor therapy and risk of hip fracture. , 2006, JAMA.
[20] I. Olkin,et al. The case of the misleading funnel plot , 2006, BMJ : British Medical Journal.
[21] P. Vestergaard,et al. Proton Pump Inhibitors, Histamine H2 Receptor Antagonists, and Other Antacid Medications and the Risk of Fracture , 2006, Calcified Tissue International.
[22] P. Moayyedi,et al. Gastro-oesophageal reflux disease , 2021, Nature Reviews Disease Primers.
[23] A. Murray,et al. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. , 2005, The American journal of medicine.
[24] K. Abe,et al. Effect of omeprazole, an inhibitor of H+, K+-ATPase, on bone resorption in humans , 1993, Calcified Tissue International.
[25] J. Pérez-Castrillón,et al. Homocysteine as a predictive factor for hip fracture in older persons. , 2004, The New England journal of medicine.
[26] E. Roughead,et al. Bisphosphonate use and subsequent prescription of acid suppressants. , 2004, British journal of clinical pharmacology.
[27] A. Hofman,et al. Homocysteine levels and the risk of osteoporotic fracture. , 2004, The New England journal of medicine.
[28] R. Valuck,et al. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. , 2004, Journal of clinical epidemiology.
[29] T. Seeman,et al. Homocysteine levels and decline in physical function: MacArthur Studies of Successful Aging. , 2002, The American journal of medicine.
[30] Rebecca S. Graves,et al. Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. , 2002 .
[31] Christopher J Cates,et al. Simpson's paradox and calculation of number needed to treat from meta-analysis , 2002, BMC medical research methodology.
[32] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[33] David Moher,et al. Meta-analysis of Observational Studies in Epidemiology , 2000 .
[34] H. Blom,et al. Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. , 1996, Biochimica et biophysica acta.